Perrigo Nutritionals Works with the American Academy of Pediatrics (AAP) on Infant Nutrition Educational Initiative
ALLEGAN, Mich., Aug. 5, 2013 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that its infant formula division, Perrigo Nutritionals, is working with the American Academy of Pediatrics (AAP) to increase educational awareness around infant nutrition, health, and feeding options. The relationship between the two organizations includes Perrigo's sponsorship of AAP's educational resource, HealthyChildren.org. The website offers pediatrician-approved health information and advice for parents and caregivers, along with interactive tools and personalized content.
Perrigo's Chairman, President and CEO Joseph C. Papa stated, "Today's parents and caregivers are faced with confusing health information, and nowhere is this truer than in the areas of infant nutrition and infant feeding options. Reports have surfaced of caregivers diluting infant formula to save money. This poses a public health risk because it reduces the amount of nutrients an infant requires. Our aim is to work with the American Academy of Pediatrics to provide accurate health and nutrition information on breastfeeding and formula feeding so that parents can improve the health of their families. Perrigo remains committed to providing quality products at affordable prices for consumers around the globe."
The American Academy of Pediatrics (AAP) and its member pediatricians dedicate their efforts and resources to the health, safety and well-being of infants, children, adolescents and young adults. The AAP has approximately 60,000 members in the United States, Canada, Mexico, and many other countries. Members include pediatricians, pediatric medical subspecialists and pediatric surgical specialists. More than 45,000 members are board-certified and called Fellows of the American Academy of Pediatrics (FAAP). For more information, visit http://www.healthychildren.org.
Perrigo Nutritionals produces Store Brand Infant Formulas in Vermont and Ohio, U.S.A. The company's FDA-inspected, ISO 9001:2008-certified facilities have been producing formulas for more than 30 years in strict compliance with good manufacturing practices (GMP). For more information, visit Perrigo infant formula websites at http://www.perrigonutritionals.com and http://www.storebrandformula.com.
From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare products. Perrigo develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements and active pharmaceutical ingredients (API). The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of logistics operations have evolved over the years to include the United States, Israel, Mexico, the United Kingdom, India, China and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).
Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended June 30, 2012, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this press release are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
For further information: Arthur J. Shannon, Vice President, Investor Relations and Communication, +1-269-686-1709, E-mail: email@example.com, Bradley Joseph, Senior Manager, Investor Relations and Communication, +1-269-686-3373, E-mail: firstname.lastname@example.org